Medicare Enrolled
Dr. Toby Bond, MD
Internal Medicine · Watkinsville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bond from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bond?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bond
Dr. Toby Bond is an internal medicine specialist in Watkinsville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bond performed 3,724 Medicare services across 2,864 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bond received a total of $14,870 from 72 pharmaceutical and/or device companies across 872 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bond is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in GA
$14,870 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,724
Medicare services
Top 9% in GA for internal medicine
2,864
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~196 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
884 | $82 | $134 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
415 | $3 | $15 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
351 | $75 | $91 |
| Annual alcohol misuse screening, 5 to 15 minutes | 349 | $17 | $52 |
| Annual depression screening | 339 | $17 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
333 | $120 | $132 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
326 | $9 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
147 | $55 | $95 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
116 | $4 | $9 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
115 | $6 | $14 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
115 | $5 | $12 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
48 | $205 | $357 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
45 | $16 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $99 | $167 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
26 | $10 | $38 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
22 | $39 | $53 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
19 | $147 | $183 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $70 | $158 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
18 | $144 | $268 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
11 | $14 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,870
Total received (2018-2024)
Avg $2,124/year across 7 years
Top 4% in GA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
872
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,806 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,976
2023
$2,148
2022
$2,312
2021
$2,022
2020
$2,341
2019
$1,919
2018
$2,152
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$265
Novo Nordisk Inc
$254
Lilly USA, LLC
$206
ABBVIE INC.
$188
Boehringer Ingelheim Pharmaceuticals, Inc.
$176
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$150
AstraZeneca Pharmaceuticals LP
$132
Phathom Pharmaceuticals, Inc.
$73
Astellas Pharma US Inc
$68
Optinose US, Inc.
$66
GlaxoSmithKline, LLC.
$64
Dexcom, Inc.
$41
PFIZER INC.
$41
Exact Sciences Corporation
$39
Tris Pharma Inc
$37
Saluda Medical Americas, Inc.
$35
IDORSIA PHARMACEUTICALS US INC
$33
Vanda Pharmaceuticals Inc.
$32
Boston Scientific Corporation
$30
Xeris Pharmaceuticals, Inc.
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Currax Pharmaceuticals LLC
$13
Top 3 companies account for 36.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,475
Amgen Inc.
$1,834
AstraZeneca Pharmaceuticals LP
$1,156
Lilly USA, LLC
$867
AbbVie Inc.
$803
Amarin Pharma Inc.
$668
ABBVIE INC.
$479
Boehringer Ingelheim Pharmaceuticals, Inc.
$473
PFIZER INC.
$472
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$432
GlaxoSmithKline, LLC.
$426
Merz North America, Inc.
$360
Teva Pharmaceuticals USA, Inc.
$330
Takeda Pharmaceuticals U.S.A., Inc.
$323
Astellas Pharma US Inc
$284
Novartis Pharmaceuticals Corporation
$242
SANOFI-AVENTIS U.S. LLC
$207
Allergan, Inc.
$159
Janssen Pharmaceuticals, Inc
$159
Biohaven Pharmaceuticals, Inc.
$154
IDORSIA PHARMACEUTICALS US INC
$144
Boston Scientific Corporation
$142
Dexcom, Inc.
$126
Egalet US Inc
$122
Biohaven Pharmaceutical Holding Company Ltd.
$108
Currax Pharmaceuticals LLC
$106
Bayer Healthcare Pharmaceuticals Inc.
$105
AbbVie, Inc.
$90
Mazor Robotics Inc.
$84
Mylan Specialty L.P.
$73
Phathom Pharmaceuticals, Inc.
$73
Bayer HealthCare Pharmaceuticals Inc.
$72
Allergan Inc.
$72
Tris Pharma Inc
$71
Genentech USA, Inc.
$69
Optinose US, Inc.
$66
Kowa Pharmaceuticals America, Inc.
$59
Exact Sciences Corporation
$59
Noven Therapeutics, LLC
$54
E.R. Squibb & Sons, L.L.C.
$51
Insulet Corporation
$49
Xeris Pharmaceuticals, Inc.
$44
Abbott Laboratories
$41
Supernus Pharmaceuticals, Inc.
$36
Horizon Therapeutics plc
$35
Saluda Medical Americas, Inc.
$35
Horizon Pharma plc
$34
Adlon Therapeutics L.P.
$34
Harmony Biosciences LLC
$33
Vanda Pharmaceuticals Inc.
$32
Radius Health, Inc.
$31
Eisai Inc.
$28
Lundbeck LLC
$27
Medtronic Vascular, Inc.
$26
EVOKE PHARMA, INC.
$26
Ironshore Pharmaceuticals Inc.
$26
Corcept Therapeutics
$25
JAZZ PHARMACEUTICALS INC.
$24
Ultragenyx Pharmaceutical Inc.
$22
Zyla Life Sciences
$20
Azurity Pharmaceuticals, Inc.
$20
Valeritas, Inc.
$20
Sunovion Pharmaceuticals Inc.
$19
VIVUS LLC
$18
Hikma Pharmaceuticals USA
$17
Eyevance Pharmaceuticals LLC
$17
Medtronic, Inc.
$16
Lucid Diagnostics Inc.
$14
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Otsuka America Pharmaceutical, Inc.
$14
Aytu BioScience, Inc
$13
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 36.8% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · AIRSUPRA · AJOVY · Aimovig · BOTOX · CALQUENCE · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · ClosureFast · Cologuard Collection Kit · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DUEXIS · Dayvigo · Dexcom G6 Transmitter · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Evoke · FANAPT · FARXIGA · FreeStyle Libre · GIMOTI · GVOKE HYPOPEN · Horizant · INVOKANA · JANUVIA · JARDIANCE · JORNAY PM · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NEXLETOL · NURTEC ODT · Natesto · Omnipod · Otezla · Ozempic · PAXLOVID · PREMARIN · PREVNAR - 13 · Prolia · QELBREE · QSYMIA · QULIPTA · QUVIVIQ · RELISTOR ORAL · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPRIX · SUNOSI · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tobradex ST · Tresiba · Trintellix · Tymlos · UBRELVY · Utibron · V-GO · VIBERZI · VOQUEZNA · VRAYLAR · VYEPTI · VYVANSE · Vascepa · VenaSeal · Veozah · Victoza · Vyvanse · WAKIX · WATCHMAN · Wegovy · XARELTO · XEOMIN · XIFAXAN · Xelstrym · Xhance · Xofluza · Xultophy 100/3.6 · Yupelri · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in GA.
Geographic Context
Internal medicine physicians within 10 mi
221
Per 100K population
516.5
County median income
$115,925
Nearest hospital
ST MARY'S HOSPITAL
11.4 mi
11.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bond is a clinical cardiology specialist, with above-average Medicare volume (top 9% in GA), with low-engagement industry engagement in the top 4% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bond experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bond performed 884 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bond receive payments from pharmaceutical companies?
Yes. Dr. Bond received a total of $14,870 from 72 companies across 872 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bond's costs compare to other internal medicine physicians in Watkinsville?
Dr. Bond's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bond) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Watkinsville
Browse internal medicine physicians in Watkinsville ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in GA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in GA
Which GA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology